115 related articles for article (PubMed ID: 37467471)
21. Differential clinical characteristics, treatment response and prognosis of locally advanced adenocarcinoma/adenosquamous carcinoma and squamous cell carcinoma of cervix treated with definitive radiotherapy.
Chen JL; Huang CY; Huang YS; Chen RJ; Wang CW; Chen YH; Cheng JC; Cheng AL; Kuo SH
Acta Obstet Gynecol Scand; 2014 Jul; 93(7):661-8. PubMed ID: 24666257
[TBL] [Abstract][Full Text] [Related]
22. Cervical cancer screening. Organised screening to avoid unnecessary conisation.
Prescrire Int; 2010 Aug; 19(108):172-7, 179. PubMed ID: 20939454
[TBL] [Abstract][Full Text] [Related]
23. Cervical screening and risk of adenosquamous and rare histological types of invasive cervical carcinoma: population based nested case-control study.
Lei J; Andrae B; Ploner A; Lagheden C; Eklund C; Nordqvist Kleppe S; Wang J; Fang F; Dillner J; Elfström KM; Sparén P
BMJ; 2019 Apr; 365():l1207. PubMed ID: 30944091
[TBL] [Abstract][Full Text] [Related]
24. Prior cervical cytology and high-risk HPV testing results for 311 patients with invasive cervical adenocarcinoma: a multicenter retrospective study from China's largest independent operator of pathology laboratories.
Xie F; Zhang L; Zhao D; Wu X; Wei M; Zhang X; Wu X; Fang H; Xu X; Yang M; Qi D
BMC Infect Dis; 2019 Nov; 19(1):962. PubMed ID: 31711435
[TBL] [Abstract][Full Text] [Related]
25. [Cervical cancer in Mecklenburg-Western Pomerania. Tumor stage, histological tumor type, age and screening participation of 985 patients].
Marquardt K; Stubbe M; Broschewitz U
Pathologe; 2016 Feb; 37(1):78-83. PubMed ID: 26660458
[TBL] [Abstract][Full Text] [Related]
26. Increasing age predicts poor cervical cancer prognosis with subsequent effect on treatment and overall survival.
Quinn BA; Deng X; Colton A; Bandyopadhyay D; Carter JS; Fields EC
Brachytherapy; 2019; 18(1):29-37. PubMed ID: 30361045
[TBL] [Abstract][Full Text] [Related]
27. Gastric-type adenocarcinoma of the cervix in patients with Peutz-Jeghers syndrome: a systematic review of the literature with proposed screening guidelines.
Gordhandas SB; Kahn R; Sassine D; Aviki EM; Baltich Nelson B; Catchings A; Liu YL; Lakhman Y; Abu-Rustum NR; Park KJ; Mueller JJ
Int J Gynecol Cancer; 2022 Jan; 32(1):79-88. PubMed ID: 34903560
[TBL] [Abstract][Full Text] [Related]
28. A population study of screening history and diagnostic outcomes of women with invasive cervical cancer.
Benard VB; Jackson JE; Greek A; Senkomago V; Huh WK; Thomas CC; Richardson LC
Cancer Med; 2021 Jun; 10(12):4127-4137. PubMed ID: 34018674
[TBL] [Abstract][Full Text] [Related]
29. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
[TBL] [Abstract][Full Text] [Related]
30. Discrepancy between Cytology and Histology in Cervical Cancer Screening: a Multicenter Retrospective Study (KGOG 1040).
Ouh YT; Park JJ; Kang M; Kim M; Song JY; Shin SJ; Shim SH; Yoo HJ; Lee M; Lee SJ; Shin W; Chong GO; Choi MC; Choi CH; Min KJ
J Korean Med Sci; 2021 Jun; 36(24):e164. PubMed ID: 34155836
[TBL] [Abstract][Full Text] [Related]
31. [Analysis of the missed diagnosis of invasive carcinoma under the microscope in HSIL diagnosed by colposcopy-guided biopsy and related influencing factors].
Qian XY; You ZX; Cao QW; Zou BB; Xing Y
Zhonghua Fu Chan Ke Za Zhi; 2018 Sep; 53(9):613-619. PubMed ID: 30293297
[No Abstract] [Full Text] [Related]
32. Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis.
Sherman ME; Lorincz AT; Scott DR; Wacholder S; Castle PE; Glass AG; Mielzynska-Lohnas I; Rush BB; Schiffman M
J Natl Cancer Inst; 2003 Jan; 95(1):46-52. PubMed ID: 12509400
[TBL] [Abstract][Full Text] [Related]
33. Risk of high-grade cervical dysplasia and gynaecological malignancies following the cytologic diagnosis of atypical endocervical cells of undetermined significance: a retrospective study of a state-wide screening population in Western Australia.
Munro A; Williams V; Semmens J; Leung Y; Stewart CJ; Codde J; Spilsbury K; Steel N; Cohen P; O'leary P
Aust N Z J Obstet Gynaecol; 2015 Jun; 55(3):268-73. PubMed ID: 26044565
[TBL] [Abstract][Full Text] [Related]
34. Histologic follow-up results in 662 patients with Pap test findings of atypical glandular cells: results from a large academic womens hospital laboratory employing sensitive screening methods.
Zhao C; Florea A; Onisko A; Austin RM
Gynecol Oncol; 2009 Sep; 114(3):383-9. PubMed ID: 19501894
[TBL] [Abstract][Full Text] [Related]
35. Cervical testing beyond the screening target age - A register-based cohort study from Finland.
Keltto N; Leivonen A; Pankakoski M; Sarkeala T; Heinävaara S; Anttila A
Gynecol Oncol; 2021 Aug; 162(2):315-321. PubMed ID: 34074539
[TBL] [Abstract][Full Text] [Related]
36. Prevalence and cumulative incidence of abnormal cervical cytology among HIV-infected Thai women: a 5.5-year retrospective cohort study.
Chalermchockcharoenkit A; Chayachinda C; Thamkhantho M; Komoltri C
BMC Infect Dis; 2011 Jan; 11():8. PubMed ID: 21211065
[TBL] [Abstract][Full Text] [Related]
37. Precancerous Lesion of the Cervix and Associated Factors Among Women of West Wollega, West Ethiopia, 2022.
Ephrem Dibisa K; Tamiru Dinka M; Mekonen Moti L; Fetensa G
Cancer Control; 2022; 29():10732748221117900. PubMed ID: 35947527
[TBL] [Abstract][Full Text] [Related]
38. High-risk HPV detection and associated cervical lesions in a population of French menopausal women.
Tifaoui N; Maudelonde T; Combecal J; Vallo R; Doutre S; Didelot MN; Nagot N; Segondy M; Boulle N
J Clin Virol; 2018 Nov; 108():12-18. PubMed ID: 30196012
[TBL] [Abstract][Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
